The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Beauty Health Company is the owner of HydraFacial, a category-creating, non-invasive skin care treatment that leaves you with a glowing face in just 30 minutes. HydraFacial has over 17,000 delivery systems in over 87 countries providing millions of treatments each year.

The Beauty Health Company: A Category-Creator In The Growing Skin Care Industry

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), formerly known as Vesper Healthcare Acquisition Corp. (the “Company”), today announced it received a notice on May 19, 2021 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the “Quarterly Report”), the Company no longer complies with the continued l

The Beauty Health Company Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report

The Beauty Health Company's (SKIN) CEO Clint Carnell on Q1 2021 Results - Earnings Call Transcript

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), today announced first quarter 2021 financial results for The HydraFacial Company (“HydraFacial”), a global category-creating beauty health company. First Quarter Financial Highlights: As previously announced by HydraFacial, Q1 net sales of $47.5 million, increased 46% and 37% from Q1 2020 and Q1 2019, respectively. Q1 delivery system sales increased to $25.6 million, compared to $14.1 million in Q1 2020 and $17.0 mil

The Beauty Health Company Reports First Quarter Results for The HydraFacial Company

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced that it will report first quarter of fiscal 2021 financial results for the HydraFacial Company (“HydraFacial”) after market close on Thursday, May 13, 2021. The Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. Investors and analysts interested

The Beauty Health Company to Report First Quarter Financial Results for The HydraFacial Company on May 13, 2021

News for The Beauty Health Company Stock (SKIN)